Page last updated: 2024-11-13

tetronasin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

tetronasin: RN refers to the Na-salt; from Streptomyces longisporoflavus [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54688698
CHEBI ID190849
MeSH IDM0156016

Synonyms (4)

Synonym
tetronasin
CHEBI:190849
3-[(2s)-1-hydroxy-2-[(1s,2s,6r)-2-[(e)-3-hydroxy-2-[(2r,3r,6s)-6-[(e,3s)-3-[(2r,3s,5r)-5-[(1s)-1-methoxyethyl]-3-methyloxolan-2-yl]but-1-enyl]-3-methyloxan-2-yl]prop-1-enyl]-6-methylcyclohexyl]propylidene]oxolane-2,4-dione
Q27274977

Research Excerpts

Dosage Studied

The dose-response relationship of the ionophore tetronasin was defined in growing-finishing cattle (84 heifers and 84 steers)

ExcerptRelevanceReference
"Two grazing experiments were conducted to evaluate the dose-response relationship of steers to the ionophore tetronasin."( Dose-response relationship of tetronasin administered to grazing steers.
Bailie, JH; Gates, RN; Hembry, FG; Roland, LT; Wyatt, WE, 1989
)
0.28
"The dose-response relationship of the ionophore tetronasin was defined in growing-finishing cattle (84 heifers and 84 steers)."( Dose-response relationship of the ionophore tetronasin in growing-finishing cattle.
Bailie, JH; Bartle, SJ; Preston, RL, 1988
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
terpene glycosideA terpenoid in which one or more hydroxy functions are glycosylated.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (21.05)18.7374
1990's11 (57.89)18.2507
2000's2 (10.53)29.6817
2010's1 (5.26)24.3611
2020's1 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (10.53%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (89.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]